United States · Bill · S
S. 1505 (116th)
Medicare Prescription Drug Fraud Prevention Act of 2019
Introduced
16 May 2019
Last action
16 May 2019 · Introduced
Status
Read twice and referred to the Committee on Finance.
Sponsors
John Cornyn, Rep. Cardin, Benjamin L. [D-MD-3]
Subjects
Healthcare
Source updated
3 January 2025
Summary
Medicare Prescription Drug Fraud Prevention Act of 2019 This bill requires prescription drug plan sponsors to report any suspicious activities relating to fraud, waste, or abuse under the Medicare prescription drug benefit and any corrective actions taken.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 May 2019
Introduced
Read twice and referred to the Committee on Finance.
Source: IntroReferral
16 May 2019
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 16 May 2019 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 16 May 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 16 May 2019
Introduced in Senate
summary · EN · 16 May 2019
Sponsors
- John Cornyn · R · Sponsor
- Rep. Cardin, Benjamin L. [D-MD-3] · D · Sponsor
- · ssfi00 · Standing
Related records
- related to ← Prescription Drug Pricing Reduction Act of 2019
- related to ← Lower Costs, More Cures Act of 2019
- related to ← Prescription Drug Pricing Reduction Act of 2020
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/1505
- Open data entity: https://api.congress.gov/v3/bill/116/s/1505
- us · 116-s-1505 · source updated 3 January 2025